BACKGROUND: External ventricular drains (EVDs) are associated with high rates of infection, and EVD infections cause substantial morbidity and mortality. OBJECTIVE: To determine whether the introduction of an evidence-based EVD infection control protocol could reduce the rate of EVD infections. METHODS: This was a retrospective analysis of an EVD infection control protocol introduced in a tertiary care neurointensive care unit. We compared rates of cerebrospinal fluid culture positivity and ventriculitis for the 3 years before and 3 years after the introduction of an evidence-based EVD infection control protocol. A total of 262 EVD placements were analyzed, with a total of 2499 catheter-days. RESULTS: The rate of cerebrospinal fluid culture positivity decreased from 9.8% (14 of 143; 11.43 per 1000 catheter-days) at baseline to 0.8% (1 of 119; 0.79 per 1000 catheterdays) in the EVD infection control protocol period (P = .001). The rate of ventriculitis decreased from 6.3% (9 of 143; 7.35 per 1000 catheter-days) to 0.8% (1 of 119; 0.79 per 1000 catheter-days; P = .02). CONCLUSION: The introduction of a simple, evidence-based infection control protocol was associated with a dramatic reduction in the risk of EVD infection. Meanwhile, another serious type of iatrogenic infection in the intensive care unit (ICU), central line-related bloodstream infections, has been largely eliminated by the use of a simple, common-sense "bundle" of measures that include hand washing, draping, wearing sterile gown and gloves, wearing a cap and mask, using chlorhexidine skin preparation, and applying a sterile dressing.
xternal ventricular drain (EVD) placement is a common procedure used to treat hydrocephalus and to monitor intracranial pressure. Unfortunately, EVDs are associated with very high rates of infection, with estimates of the incidence of EVD infection typically ranging from about 5% to . 20%.
1,2 EVD infections and associated clinical ventriculitis are, in turn, a cause of significant morbidity and mortality. 2 Several approaches to reduce the risk of EVD infection have been studied such as the use of antimicrobial EVD catheters, 3, 4 prophylactic systemic antibiotics, 5 and various degrees of catheter tunneling, 6 with various degrees of success.
Meanwhile, another serious type of iatrogenic infection in the intensive care unit (ICU), central line-related bloodstream infections, has been largely eliminated by the use of a simple, common-sense "bundle" of measures that include hand washing, draping, wearing sterile gown and gloves, wearing a cap and mask, using chlorhexidine skin preparation, and applying a sterile dressing.
We hypothesized that a comprehensive approach to EVD infection control, combining several proven measures in an overlapping fashion, would have a significant impact on EVD infection rates. We present here the positive impact of introducing an EVD infection control protocol on EVD infection rates in the ICU.
Participants
We included cases of EVD placement performed in the ICU in 2005 to 2007 (baseline period) and 2009 to 2011 (EVD infection control protocol period), excluding a gap year (2008) during which the elements of the infection control protocol were sequentially adopted and education on the various steps of the protocol was undertaken among the operating physicians and bedside ICU nurses. The EVD infection control protocol period began January 1, 2009 , when the ICU adopted the protocol as part of the official ICU policies and procedures documentation.
We excluded patients with preexisting central nervous system infection such as infected ventriculoperitoneal shunts and patients who had an EVD that was placed outside our ICU (eg, in the operating room or in another hospital). Data were obtained retrospectively by direct physical chart review of the electronic medical record and programmer query of clinical and microbiological databases. The initial screen for case ascertainment was by programmer query on procedure code 02.2 (ventriculostomy), and direct physician chart review via the electronic medical record was used to specifically include only cases of EVDs placed in the ICU, excluding other procedures captured under code 02.2 such as endoscopic third ventriculostomy or Ommaya reservoir placement.
A total of 262 EVD placements over 6 years were analyzed, with a total of 2499 catheter-days.
Data Sources/Measurements
We obtained microbiological data from both programmer query of a centralized microbiology laboratory database and physician review of the electronic medical record for all EVD cases. Cerebrospinal fluid (CSF) culture positivity was defined as growth of 1 or more organisms from a CSF sample obtained from a ventriculostomy catheter placed in the ICU, a Gram stain positive for organisms from such a specimen, or both. Ventriculitis was defined as clinical documentation of suspected ventriculitis and/or treatment with antibiotics for this purpose and the presence of a positive CSF culture or a CSF profile consistent with infection. A CSF profile consistent with infection was defined as low CSF glucose (, 40 mg/dL) and an elevated CSF white blood cell count (. 5 per 1 mL) out of proportion to the degree of red blood cell elevation, with a correction of 1 white blood cell allowed per 1000 red blood cells. We included the cell and protein indexes to account for patients with intraventricular hemorrhage. In other words, when clinical suspicion of infection was encountered (eg, as a result of new or increased fever, new or rising CSF white blood cell count, or worsened mental status examination) in the presence of microorganisms isolated on CSF Gram stain or culture, the case was coded as positive for ventriculitis. Our definition of ventriculitis is compatible with published standards according to the Centers for Disease Control and Prevention, which specify meningitis/ventriculitis (code CNS-MEN) according to the following criteria: presence of organisms cultured from CSF or fever/ headache/stiff neck/meningeal signs/cranial nerve signs/or irritability and the institution of antimicrobial therapy and at least 1 of the following: increased CSF white blood cells, increased CSF protein, or decreased CSF glucose; organisms on CSF Gram stain; positive blood culture; positive CSF antigen test; or diagnostic single-antibody titer (IgM) or 4-fold increase in paired sera (IgG) for pathogen. 7 Processing and culturing of microbiological specimens were performed in a high-volume regional core laboratory. Protocols for specimen handling, processing, and incubation times did not change during the course of our study period.
The EVD Infection Control Protocol
In the baseline period (before institution of the EVD infection control protocol), techniques for EVD insertion and maintenance (eg, the nature of the sterile placement procedure, dressing, and method of drawing CSF or flushing an EVD) were up to the operating physician. During the baseline period, non-antibiotic-impregnated catheters were used. All catheters in the baseline period were Medtronic EDM ventricular catheters.
In the EVD infection control protocol period, a set of formal EVD infection control policies and procedures were adopted in the ICU that established strict standards for placement of EVDs (Table 1 and Figure 1 ) and manipulation of EVDs for CSF draws or flushing (Table 1 and Figure 2 ). The antibiotic-impregnated catheter used in the EVD infection control protocol period was the Cook/Medtronic VentriClear rifampin/minocycline-impregnated ventricular catheter. All physicians involved with EVD placement and maintenance and all ICU staff nurses were in-serviced during the gap year, and all operating physicians agreed to practice according to the new protocols. Education on the protocol was provided through face-to-face meetings and Web-based multimedia (videos and slide talks). In addition, summary posters similar to Figure 1 were placed in prominent positions in the neurosurgery clinic and in the neuro-ICU as an aide-mémoir.
In both the baseline period and the EVD infection control protocol period, CSF sampling was performed for unexplained fever (temperature . 101°F)/ leukocytosis (. 12 500 per 1 mL) or fever/leukocytosis with worsened neurological status. Standard workup for fever/leukocytosis without worsened neurological status included respiratory Gram stain and culture, urinalysis, urine microscopy, urine culture, and paired blood cultures. Given the concern that frequent manipulation may increase the risk of infection and on the basis of studies demonstrating a lack of utility of routine ventriculostomy CSF sampling, [8] [9] [10] routine or scheduled CSF sampling was not performed in either period. Routine CSF sampling was also not performed at the time of placement in either period.
Statistical Methods
Categorical data in contingency tables were analyzed with the Fisher exact test. Continuous measures were summarized with median and interquartile range and analyzed with the nonparametric Kruskal-Wallis equality-of-populations rank test. Multivariable modeling was performed with logistic regression with predictors entered if a significance of P , .05 was met in univariable association; age and sex were additionally controlled for in all models. Statistical analyses were performed with Stata MP version 12.1 (StataCorp, College Station, Texas). Sample-size calculations to estimate the number of years required for the EVD infection control protocol period were performed with GraphPad StatMate version 2.0 software, with the following assumptions: approximately 50 EVD placements per year (based on 143 placements over 3 years in the baseline period), a baseline rate of CSF infection of approximately 10%, and an ability to detect a decrease in infection rate to # 3%, with a power (12b) of 80% and an a of 0.05 (2 tailed).
Standard Protocol Approvals, Registrations, and Patient Consents
Our Institutional Review Board approved this retrospective study with waiver of informed consent.
RESULTS

Participants
Patients in the baseline and EVD infection control protocol periods were similar, except that in the EVD infection control protocol period, more patients were female, more patients had diabetes mellitus, and the average duration of EVD placement was slightly longer (Table 2) .
Main Results
The rate of CSF culture positivity decreased from 9.8% (14 of 143) at baseline to 0.8% (1 of 119) in the EVD infection control protocol period (P = .001; Figure 3A ). The rate of ventriculitis decreased from 6.3% (9 of 143) to 0.8% (1 of 119; P = .02; Figure 3C ). When expressed as infections per 1000 catheter days, A wide area of the patient's hair (A) is clipped to an area large enough to eventually dress with a medium-sized transparent dressing film. Chlorhexidine-alcohol is then applied in a first skin preparation (A, left). Full patient draping is followed by a second chlorhexidine-alcohol skin preparation with the surgeon wearing gown, gloves, cap, and mask (A, center), and full barrier precautions are used throughout (A, right). A minocycline/rifampin antibiotic-impregnated EVD catheter is tunneled 3 to 5 cm and then secured with a curvilinear line of surgical staples (B). After Benzoin tincture is applied to the skin broadly and allowed to fully dry, a chlorhexidine-eluting patch is applied over the exit site (without wrapping the patch around the catheter), and a medium-sized transparent dressing film is applied (B). The borders of the transparent dressing film and the catheter are further secured with adhesive strips (B). Additional information on placement and dressing available at: www.cleanbrain.org.
the rate of CSF culture positivity dropped from 11.43 to 0.79, and the rate of ventriculitis dropped from 7.35 to 0.79.
In the baseline period, the 14 infections occurred a median of 8 days after EVD placement (interquartile range, 4-12 days). After the introduction of the infection control protocol, a single infection occurred at 11 days after placement ( Figure 3B ). The single patient with an infection during the EVD infection control protocol period removed his own EVD approximately 2 days before developing culture-positive ventriculitis.
Organisms cultured from CSF in the baseline period were Staphylococcus epidermidis (n = 4), Coagulase-negative Staphylococcus (n = 4), Staphylococcus capitis (n = 1), Staphylococcus aureus (n = 1), FIGURE 2. Elements of the external ventricular drain (EVD) infection control protocol for EVD manipulation (cerebrospinal fluid draws or flushing). Supplies are arranged outside the sterile field (A): 70% isopropyl alcohol, a kidney basin, and several 10-mL vials of sterile, preservative-free normal saline. Supplies are then opened onto a sterile field created with a large sterile drape over the patient (B): several chlorhexidine-alcohol swabs, several sterile 10-mL syringes, a surgical sponge, and sterile Luer-fitting port caps. Before gowning and gloving, the 3-way stopcock on the EVD port is turned to 45°("off" to all directions) and submerged in 70% isopropyl alcohol solution (C). (This step is not performed on the sterile field.) The intensive care unit (ICU) nurse holds the EVD line over the sterile field without allowing the tubing to contact the field (D), and the physician dons cap, mask, sterile gown, and sterile gloves. The physician then cleanses the entire region of the port with a chlorhexidine-alcohol swab. The old port cap is discarded; the port is inverted; and fluid in the port is shaken out onto a surgical sponge (E). The port is cleaned again and then filled with chlorhexidine-alcohol solution (F). The port is inverted, and chlorhexidine-alcohol solution is shaken out onto the surgical sponge (G). Steps F and G are repeated several times. The physician uses the sterile 10-mL syringes to draw up sterile, preservative-free normal saline in sterile fashion from the ICU nurse. The port is rinsed with sterile, preservative-free normal saline, and the port is inverted to discard (H). The rinse step is repeated several times. A sterile 10-mL syringe is then attached to the port for CSF draw or flushing (I). Additional information about EVD manipulation techniques available at: www.cleanbrain.org.
Stenotrophomonas maltophilia (n = 1), vancomycin-resistant Enterococcus (n = 1), Candida species (n = 1), and Exophiala spinifera (n = 1). The organism cultured from CSF in the 1 positive case in the EVD infection control protocol period was Streptococcus pneumoniae.
All-cause in-hospital mortality was 33.6% (48 of 143) at baseline and 31.9% (38 of 119) in the EVD infection control period (P = .44).
In univariable analysis, presence in the EVD infection control protocol period and duration of EVD placement were each significant predictors of CSF culture positivity and ventriculitis. The other factors listed in Table 2 were not predictors of CSF culture positivity or ventriculitis. In multivariable logistic regression, presence in the EVD infection control protocol period and duration of EVD placement were both independent predictors of both CSF culture positivity and ventriculitis (Table 3) .
DISCUSSION Key Results
We demonstrate that the introduction of a simple, evidencebased EVD infection control protocol is associated with a dramatic reduction in EVD infections.
Previous studies have examined the impact of specific measures on EVD infection control. Whenever possible, we based the components of our protocol on evidence from prior studies. Two randomized controlled trials have shown efficacy of minocycline/ rifampin-impregnated EVD catheters 3 or silver-impregnated catheters 4 in reducing EVD infection rates. A chlorhexidinealcohol solution instead of a povidone-iodine solution was chosen for skin preparation on the basis of studies demonstrating superiority of a chlorhexidine-alcohol solution to prevent other types of surgical-site infections, eg, clean-contaminated surgery. 11, 12 The use of a single preprocedural dose of systemic antibiotic and standing prophylactic systemic antibiotics were based on a lack of evidence without supporting standing prophylactic antibiotics and a randomized controlled trial showing that antibiotic-impregnated EVD catheters were as effective as prophylactic systemic antibiotics in preventing CSF infection. 5 Use of a chlorhexidine-eluting patch has been reported to be a cost-effective means to reduce infection rates with central lines. 13 Modest degrees of subcutaneous EVD tunneling have been associated with reduced rates of infection, but longer tunneling has not. 6 Other bundle approaches to infection control in the ICU have been shown to be effective. Use of a protocol of hand washing, broad draping, sterile gloves and gown, cap and mask, chlorhexidine skin preparation, strict sterile technique, and application of a sterile dressing has been shown to dramatically reduce the rate of catheter-related bloodstream infections with central venous catheters to nearly zero.
14 This "Pronovost bundle" has since been widely adopted and has been shown to have a generalizable 15 and sustained 16 effect. The positive impact of the Pronovost bundle for central line placement serves as a proof-of-principle study from the perspective of preventing EVD infections in the ICU. Initial attempts to use a similar bundle approach with EVD placement have been successful but have not shown the same dramatic, near-zero rates of infection seen in studies of central line infection control. In 1 study that combined several elements into an infection control protocol for EVDs, the rate of infection decreased from 27% to 12%. 17 In other studies of EVD infection control bundles, the rate of infection decreased from 16.2% to 11.3% 18 and from 12.2% to 5.7%.
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What was different about our approach compared with prior studies? First, our EVD infection control protocol included a more extensive set of measures (Table 1 and Figures 1 and 2 ), in some cases overlapping measures (such as the use of both an antibioticimpregnated catheter and a chlorhexidine-eluting patch). Another specific extension compared with prior work was our inclusion of specific measures to reduce the risk of contaminating the EVD system during manipulation for CSF draws or flushing (Table 1 and Figure 2 ). Given that antibiotic-impregnated catheters have been found to reduce the rate of EVD infections to less than half of the baseline rate 3, 4, 20 and ventriculoperitoneal shunt infections by a similar degree, 21, 22 it seems likely that substantial gains are made by the use of this type of catheter and that the additional gains we observed are due to measures such as the broad preparation, the chlorhexidine-eluting patch, and the strict protocols for sterile placement and manipulation.
Limitations
Our study has limitations. Similar to the Pronovost et al 14 study, ours is a before/after study design, and patients were not randomized. Other factors beyond those included in our protocol may have changed over time and confounded our comparison of the before and after periods. Differences in underlying diagnoses such as traumatic brain injury or brain mass might also have contributed to differences in infection rates. Although our study was adequately powered to detect the difference in infection rates we observed, it is a single-center study performed in a center without trainees. It will be important to confirm that our approach is generalizable by verifying our results in other settings. Because of the concern that frequent manipulation may increase the risk of infection and based on studies demonstrating a lack of utility of routine ventriculostomy CSF sampling, 8, 9 we did not perform routine CSF sampling in either period. However, this approach The incidence of cerebrospinal fluid (CSF) culture positivity decreased from 9.8% in the baseline period to 0.8% in the EVD infection control protocol period (A; P = .002, Fisher exact test). Time (in days) from EVD placement to CSF culture positivity is displayed for all infection in both periods (B). The incidence of ventriculitis decreased from 6.3% in the baseline period to 0.8% in the EVD infection control protocol period (C; P = .02, Fisher exact test). could not have introduced a sampling bias toward fewer detected infections in the EVD infection control group because this policy was in place in both periods. Our detection of 9.8% CSF culture positivity in the baseline period is consistent with prior estimates of EVD infection rates, 1,2 suggesting that we did not underestimate infection rates by choosing to avoid routine CSF sampling.
How might our study affect clinical practice and further research in this field? At minimum, increased awareness of methods to decrease EVD infection rates will lead to more methodical efforts to perform infection surveillance in this patient population. 23 In addition, we hope that it will be easy for other centers to adopt the infection control protocol presented here because it appears to be effective but is not overly complex. To support adoption of the protocol, we have made multimedia training resources available at www.cleanbrain.org. From the research perspective, a reasonable next step would be a multicenter external validation study using a similar before/after design, perhaps with a staggered introduction approach to control for the impact of changes in practice over time that are not part of the protocol.
CONCLUSION
The introduction of a simple, evidence-based infection control protocol was associated with a dramatic reduction in the risk of EVD infection.
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